To confirm this, we compared previously published BM CD44 mRNA levels with the percentage of AML blasts in the BM [32] and found a significant positive correlation (r = 0.32, p < 0.0001; Figure 3f). The gene discussed is CD44; the disease is acute myeloid leukemia.